Pål Skage Dahlberg

Pål Skage Dahlberg has a diverse work experience spanning multiple industries. Pål Skage is currently working as a Business Strategy Analyst at Nykode Therapeutics since January 2022. Prior to this, they worked as a Research Scientist at Oslo University Hospital from August 2014 until January 2022. Pål also served as the Chief Executive at TOD Diagnostics AS from May 2011 to August 2014. Before that, they worked as a Product Specialist at VWR International from October 2008 to August 2014. Pål Skage also held a position as a Product Manager OEM/IVD Immunoassay at Invitrogen Dynal for a brief period in 2008. Pål's earlier experience includes working as a Product Manager at Merck Serono from an unspecified period in 2006 until 2008.

Pål Skage Dahlberg pursued their Bachelor's degree in Biology at the University of Oslo (UiO) from 1995 to 2001. Continuing their academic journey, they then enrolled in the same university to obtain their Master's degree in Genetics, which they successfully completed from 2001 to 2003.